BioCentury
ARTICLE | Financial News

Aeglea completes IPO

April 11, 2016 7:00 AM UTC

Aeglea BioTherapeutics Inc. (NASDAQ:AGLE), Austin, Texas Business: Cancer, Endocrine/Metabolic Date completed: 2016-04-07 Type: IPO Raised: $50 million Shares: 5 million Price: $10 Shares after offeri...